Aakaar Medical Technologies Limited has filed its Structured Digital Database (SDD) compliance certificate with the National Stock Exchange of India Limited for the financial year ended March 31, 2026. The submission was made on May 09, 2026, pursuant to Regulations 3(5) and 3(6) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, read with NSE Circular no. NSE/CML/31 dated October 18, 2024. The certificate was signed by Anoopkumar Pillai, Company Secretary & Compliance Officer of the company.

SDD Compliance Certificate Highlights

The compliance certificate was issued by Devendra V Deshpande, Practicing Company Secretary and Proprietor of DVD & Associates, Company Secretaries, based in Pune. The certificate confirms the company's adherence to the SDD requirements under the PIT Regulations for the financial year ended March 31, 2026. The following key compliance points were certified:

• The company has a Structured Digital Database in place
• Controls exist as to who can access the SDD
• All UPSI disseminated during the year have been captured in the database
• The system has captured the nature of UPSI along with date and time
• The database has been maintained internally, and an audit trail is maintained
• The database is non-tamperable and has the capability to maintain records for 8 years

UPSI Events and Technical Issue

The certificate details the total number of UPSI events required to be captured and the company's compliance status for the financial year.

The company informed the certifying authority of a temporary technical issue in its SDD during February 2026. The issue was promptly resolved, and all relevant UPSI-related entries were duly recorded. No data loss or integrity issues were reported, and the matter was placed before the Audit Committee and noted.

Certification Details

The compliance certificate was issued by DVD & Associates, Company Secretaries, with offices in Pune, Mumbai, Kolhapur, Yavatmal, and Dubai. The relevant certification details are as follows:

Aakaar Medical Technologies confirmed that no non-compliance was observed during the financial year ended March 31, 2026, underscoring the company's adherence to SEBI's insider trading prevention framework.

Aakaar Medical Technologies Limited has announced the scheduling of its H2 & FY26 earnings conference call on Friday, May 15, 2026, at 4:30 PM IST. The call will be held post the announcement of the company's audited financial results for the year ended March 31, 2026, as approved by the Board of Directors at its meeting on the same date. The company had earlier communicated the Board meeting schedule through a letter dated April 01, 2026.

Earnings Call Details

The earnings call has been organised by Go India Advisors and will provide an opportunity for investors and stakeholders to engage with the company's senior leadership on its financial performance. The key company participants scheduled to be present are outlined below:

Dial-In Information

Participants can join the call using the following dial-in details. Pre-registration is mandatory to receive call login credentials via the registration link provided by Go India Advisors.

Regulatory Compliance

The intimation has been filed under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was submitted to the National Stock Exchange of India Limited on May 07, 2026, and signed by Anoopkumar Pillai, Company Secretary and Compliance Officer of Aakar Medical Technologies Ltd.

Further details and updates will be hosted on the company's website at https://aakaarmedical.in/disclosures-as-per-regulation-46-of-the-sebi-lodr-regulations/ . For additional information, stakeholders may contact Go India Advisors through Sheetal Khanduja at sheetal@goindiaadvisors.com (+91 9769364166) or Soumya Chhajed at soumya@goindiaadvisors.com (+91 8619707750).